Economic Geology, ISSN 0361-0128, 12/2016, Volume 111, Issue 8, pp. 1963 - 1984
The Kiruna-type Pea Ridge iron oxide-apatite (IOA) deposit is hosted by a sequence of 1.47 Ga rhyolite tuffs of the St. Francois Mountains, southeast Missouri,...
KIRUNA-TYPE | GEOCHEMISTRY & GEOPHYSICS | MAGNETITE-APATITE DEPOSITS | CENTRAL IRAN | (Y+REE)-PHOSPHATE MINERALS | ELECTRON-MICROPROBE ANALYSIS | INDUCED NUCLEATION | RARE-EARTH-ELEMENTS | REPLACEMENT REACTIONS | EXPERIMENTAL CALIBRATION | IRON-ORES
KIRUNA-TYPE | GEOCHEMISTRY & GEOPHYSICS | MAGNETITE-APATITE DEPOSITS | CENTRAL IRAN | (Y+REE)-PHOSPHATE MINERALS | ELECTRON-MICROPROBE ANALYSIS | INDUCED NUCLEATION | RARE-EARTH-ELEMENTS | REPLACEMENT REACTIONS | EXPERIMENTAL CALIBRATION | IRON-ORES
Journal Article
American Journal of Physiology - Regulatory Integrative and Comparative Physiology, ISSN 0363-6119, 10/2018, Volume 315, Issue 4, pp. R668 - R668
Journal Article
Revista de Psicologia del Trabajo y de las Organizaciones, ISSN 1576-5962, 12/2017, Volume 33, Issue 3, pp. 165 - 173
This study investigates the multiple mediating roles of work engagement and work commitment in the job crafting-job satisfaction relationship. The participants...
Job crafting | Electrical/electronic technology education lecturers | Work engagement | Job satisfaction | Commitment | Mediation
Job crafting | Electrical/electronic technology education lecturers | Work engagement | Job satisfaction | Commitment | Mediation
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 2017, Volume 69, Issue 7, pp. 777 - 785
BACKGROUND: GLORIA-AF (Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation) is a prospective, global registry...
registry | oral anticoagulation | atrial fibrillation | CARDIAC & CARDIOVASCULAR SYSTEMS | MANAGEMENT | GUIDELINES | RISK | EUROPEAN-SOCIETY | ATRIAL-FIBRILLATION | ANTITHROMBOTIC TREATMENT | THERAPY | WARFARIN | ORAL ANTICOAGULANTS | Stroke - prevention & control | Prospective Studies | Cross-Sectional Studies | Antithrombins - therapeutic use | Humans | Middle Aged | Atrial Fibrillation - complications | Male | Dabigatran - therapeutic use | Stroke - etiology | Internationality | Fibrinolytic Agents - therapeutic use | Female | Registries | Aged | Hypertension | Heart failure | Cardiac arrhythmia | Anticoagulants | Stroke | Statistical analysis | Cardiovascular disease | Alcohol | Valves | Family medical history | Patients | Demographics | Onsite | Quality | Data collection | Trends | Clinical medicine | Diabetes | Age
registry | oral anticoagulation | atrial fibrillation | CARDIAC & CARDIOVASCULAR SYSTEMS | MANAGEMENT | GUIDELINES | RISK | EUROPEAN-SOCIETY | ATRIAL-FIBRILLATION | ANTITHROMBOTIC TREATMENT | THERAPY | WARFARIN | ORAL ANTICOAGULANTS | Stroke - prevention & control | Prospective Studies | Cross-Sectional Studies | Antithrombins - therapeutic use | Humans | Middle Aged | Atrial Fibrillation - complications | Male | Dabigatran - therapeutic use | Stroke - etiology | Internationality | Fibrinolytic Agents - therapeutic use | Female | Registries | Aged | Hypertension | Heart failure | Cardiac arrhythmia | Anticoagulants | Stroke | Statistical analysis | Cardiovascular disease | Alcohol | Valves | Family medical history | Patients | Demographics | Onsite | Quality | Data collection | Trends | Clinical medicine | Diabetes | Age
Journal Article
Studies in Mycology, ISSN 0166-0616, 06/2014, Volume 78, Issue 78, pp. 141 - 173
comprises a diverse group of species based on morphological, physiological and phylogenetic characters, which significantly impact biotechnology, food...
Fungal identification | Media | Phylogeny | Nomenclature | DESORPTION-IONIZATION-TIME | METABOLITES | FUNGI | SECTION FUMIGATI | INTERNAL TRANSCRIBED SPACER | SP NOV | MALDI-TOF MS | TERREUS ACCESSORY CONIDIA | POLYPHASIC TAXONOMY | DNA | MYCOLOGY | Aspergillus | Identification and classification
Fungal identification | Media | Phylogeny | Nomenclature | DESORPTION-IONIZATION-TIME | METABOLITES | FUNGI | SECTION FUMIGATI | INTERNAL TRANSCRIBED SPACER | SP NOV | MALDI-TOF MS | TERREUS ACCESSORY CONIDIA | POLYPHASIC TAXONOMY | DNA | MYCOLOGY | Aspergillus | Identification and classification
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2016, Volume 375, Issue 4, pp. 311 - 322
Patients with type 2 diabetes and high cardiovascular risk were assigned to receive either the glucagon-like peptide 1 analogue liraglutide or placebo. The...
TRIALS | MEDICINE, GENERAL & INTERNAL | PANCREATITIS | Hypoglycemic Agents - therapeutic use | Myocardial Infarction - epidemiology | Double-Blind Method | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Male | Treatment Outcome | Liraglutide - adverse effects | Diabetes Mellitus, Type 2 - mortality | Liraglutide - therapeutic use | Cardiovascular Diseases - mortality | Female | Stroke - epidemiology | Aged | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Diabetes Mellitus, Type 2 - complications | Gastrointestinal Diseases - chemically induced | Type 2 diabetes | Complications and side effects | Treatment outcome | Usage | Care and treatment | Vasomotor conditioning | Analysis | Dosage and administration | Research | Liraglutide | Myocardial infarction | Cerebral infarction | Glucagon | Diabetes mellitus | Pancreatitis | Cardiovascular disease | Side effects | Death | Blood pressure | Diabetes | Cardiovascular diseases | Drug therapy | Diabetes mellitus (non-insulin dependent) | Heart diseases | Glucagon-like peptide 1
TRIALS | MEDICINE, GENERAL & INTERNAL | PANCREATITIS | Hypoglycemic Agents - therapeutic use | Myocardial Infarction - epidemiology | Double-Blind Method | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Male | Treatment Outcome | Liraglutide - adverse effects | Diabetes Mellitus, Type 2 - mortality | Liraglutide - therapeutic use | Cardiovascular Diseases - mortality | Female | Stroke - epidemiology | Aged | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Diabetes Mellitus, Type 2 - complications | Gastrointestinal Diseases - chemically induced | Type 2 diabetes | Complications and side effects | Treatment outcome | Usage | Care and treatment | Vasomotor conditioning | Analysis | Dosage and administration | Research | Liraglutide | Myocardial infarction | Cerebral infarction | Glucagon | Diabetes mellitus | Pancreatitis | Cardiovascular disease | Side effects | Death | Blood pressure | Diabetes | Cardiovascular diseases | Drug therapy | Diabetes mellitus (non-insulin dependent) | Heart diseases | Glucagon-like peptide 1
Journal Article